SCHEMBL6616231

SCHEMBL6616231

C=CCNC(=O)NCc1ccc(OC)cc1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.61
NPC1 O15118 4/20 0.61
RAB9A P51151 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.59
POLB P06746 1/20 0.55
CASR P41180 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
ALDH1A1 P00352 4/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HTT P42858 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
KDM4E B2RXH2 1/20 0.51
PPIB P23284 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24576223 0.87 NPC1 (0.71) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL5759180 0.83 ALDH1A1 (0.59) SMN1; SMN2POLBALDH1A1MEN1KMT2A
SCHEMBL4587584 0.83 NPC1 (0.61) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL3063620 0.82 ALDH1A1 (0.76) PKMPOLBALDH1A1MEN1KMT2A
SCHEMBL6616236 0.81 RAB9A (0.66) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL16562080 0.81 NPC1 (0.77) NPC1RAB9ASMN1; SMN2POLBCASR
SCHEMBL5518470 0.81 NPC1 (0.63) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL4743993 0.80 TGM2 (0.63) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL27582701 0.80 NPC1 (0.61) PKMNPC1RAB9ASMN1; SMN2POLB
SCHEMBL17916794 0.80 SMN1; SMN2 (0.88) NPC1RAB9ASMN1; SMN2POLBHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412338-A1 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS Neurocrine Biosciences, Inc. (US) 2004-04-28 EP disclosed
WO-2003011839-A1 1,3,5-TRIAZINE-2,4,6-TRIONES, PREPARATION AND USE AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 2003-02-13 WO disclosed